Focal (Partial) Seizures in Adults Aged 16–59
This protocol addresses the management of focal (partial) seizures in younger adults between 16 and 59 years of age — seizures originating within networks limited to one hemisphere, which may present with subjective (aura), motor, autonomic, or dyscognitive features.
Clinical Scenario
Focal onset seizures in this adult age group are characterized by their partial, hemisphere-limited origin. The population targeted here — adults aged 16 to 59 — represents the working-age cohort in whom persistent seizure burden and treatment refractoriness carry significant quality-of-life implications.
Treatment Approach (Partial Overview)
When focal seizures prove medically refractory, the protocol incorporates non-pharmacological and interventional options — including a specific surgical approach targeting the seizure focus, a specialised dietary strategy, and neurostimulation-based alternatives for patients who are not surgical candidates or in whom surgery has not been effective. The complete decision sequence, patient-selection criteria, and full regimen detail are available via the structured protocol.
Full algorithm, eligibility criteria, and clinical decision points are accessible through the protocol below.
References
- Seizure originating within networks limited to one hemisphere characterized by subjective (aura), motor, autonomic, and dyscognitive features
- Younger adults (16 to 59 years of age)
- For patients with seizures that are not controlled with these agents, alternative treatments include surgical resection of the seizure focus, ketogenic diets, vagus nerve stimulators, and implantable brain neurostimulators.
- Surgical resection of the seizure focus in appropriately selected patients often results in decreased frequency or elimination of seizures with improvement in quality of life.
- The ketogenic diet, a high-fat, low-carbohydrate, and low-protein diet, induces ketone body formation.
- Vagus nerve stimulation may increase seizure-free time in patients with medically refractory epilepsy who are not candidates for surgery or in whom surgery has been ineffective.
- It is approved by the U.S. Food and Drug Administration for use in persons older than 12 years.
- Responsive neurostimulation is another approach to treating medically refractory partial-onset seizures.
View source ↗